Modular in vivo antibody–ADC click to reverse drug resistance in tumours
A new modular approach using click chemistry to assemble antibody-drug conjugates in vivo aims to reverse drug resistance in tumors.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Researchers have developed a method using click chemistry to allow two antibodies to find each other and assemble into a cancer drug within the body. According to Nature, this modular in vivo antibody-ADC click is designed to reverse drug resistance in tumors.
Coverage from EurekAlert! and WashU Medicine emphasizes that these click chemistry antibodies bind to pancreatic cancer cells. The Lebanon Democrat describes the development as a 'game changer' that turns cancer's defenses against itself.
Future focus remains on the practical application of this drug design approach, as George L. Kumar explores the potential for antibodies to assemble as medication, according to Oncodaily.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 25m ago.
Quick answers
What is the primary goal of this new drug approach?
The goal is to reverse drug resistance in tumors through a modular in vivo antibody-ADC click.
Which specific type of cancer is mentioned in the coverage?
Coverage from EurekAlert! specifies that these antibodies bind to pancreatic cancer cells.
What technique is used to assemble the drug?
The drug utilizes click chemistry to allow antibodies to find each other and assemble.
Coverage (5)
- ‘Game changer’ drug turns cancer’s defenses against itself Lebanon Democrat · 1d ago
- Click chemistry antibodies bind to pancreatic cancer cells (IMAGE) EurekAlert! · 1d ago
- New approach to designing drugs supercharges cancer medication WashU Medicine · 1d ago
- George L․ Kumar: What If Two Antibodies Could Find Each Other and Assemble a Cancer Drug? Oncodaily · 1d ago
- Modular in vivo antibody–ADC click to reverse drug resistance in tumours Nature · 1d ago
Topics
Related trends
Can Ozempic prevent cancer? A doctor explains why the headlines are easy to misread
Medical discussions are intensifying over whether GLP-1 medications like Ozempic can prevent cancer or influence oncology recovery.
A breakthrough in pancreatic cancer has experts excited
A new treatment for metastatic pancreatic cancer and KRAS-mutated cancers is generating optimism among experts and patients.
Pancreatic cancer breakthrough has big implications for early detection effort - San Diego Union-Tribune
An experimental pill called daraxonrasib is showing promising early results and gaining regulatory attention for treating pancreatic cancer.
Harvard gastroenterologist reveals 7 silent symptoms of pancreatic cancer everyone should know
Medical experts are highlighting seven 'silent' symptoms of pancreatic cancer to improve early detection and awareness.
Deadly drug-resistant fungal infections rising in the U.S.
The U.S. is seeing a rise in deadly, drug-resistant fungal infections that threaten hospital environments.
Drug Stops 90% of Pancreatic Cancer Migration in Lab Tests
Researchers have discovered a drug that blocks 90% of pancreatic cancer cell migration in laboratory tests.